Biopromic has been nominated to the EIT Health Catapult program

EIT Health Scandinavia is announcing the six companies nominated for the semi-finals stage of the EHC in all three categories, BioTech, MedTech and Digital Health. Biopromic is one of the 3 Medtech companies nominated this year.
The European Health Catapult (EHC) is a training and competition platform, jointly organised by EIT Health and Health Axis Europe, that includes several opportunities for companies to present in front of experts and international investors. It awards the best-of-the-best business concepts from medtech, biotech and digital health across Europe. EHC sources and accelerates 21 European start-ups in biotech, medtech and digital health which receive high-quality training in business plan modelling, deal negotiation and pitch training, as well as a facilitated access to top level investors.